Thursday, 17 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14409
Articles
Company
Deals
Koutech Robotics Secures Series A Funding for Surgical Innovation
February 6, 2025
Company
Drug
CARsgen Therapeutics Presents Positive Phase Ib/II Data for CT053 at CAR-TCR Summit
February 6, 2025
Company
Deals
Joincare Pharmaceuticals Prices GDRs on SIX Swiss Exchange
February 6, 2025
Company
Northeast Pharmaceutical to Invest in Shanghai Subsidiary for ADC and CAR-T Development
February 6, 2025
Policy / Regulatory
Beijing Designates 923 Medical Entities for National Reimbursement Drug List
February 6, 2025
Company
Lee’s Pharmaceutical Reports H1 Revenue Growth Amid Product Portfolio Shift
February 6, 2025
Company
Drug
Junshi Biosciences’ Tuoyi Approved for First-Line NSCLC Treatment in China
February 6, 2025
Company
Drug
Sun-Novo’s STC007 Gains NMPA Approval for Postoperative Pain Study
February 6, 2025
Company
Deals
WuXi Biologics Partners with Elpiscience for Macromolecule Development
February 6, 2025
Company
Drug
Tasly Pharmaceuticals Gains NMPA Approval for B1344 Diabetes Study
February 6, 2025
Company
Drug
Clover Biopharmaceuticals Reports Positive Phase III Data for COVID-19 Vaccine SCB-2019
February 6, 2025
Company
Drug
RemeGen Announces Positive Phase III Results for Telitacicept in SLE
February 6, 2025
1
2
…
1,129
1,130
1,131
1,132
1,133
…
1,200
1,201
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?